Evidence map›Paper›PMID 39574720›Full record

ArticlebioRxiv : the preprint server for biology2024

Cerebellar-Prefrontal Connectivity Predicts Negative Symptom Severity Across the Psychosis Spectrum.

Sean A Yarrell, Sophia H Blyth, Baxter P Rogers, Anna Huang, Alexandra B Moussa-Tooks, Neil D Woodward, Stephan Heckers, Roscoe O Brady, Heather Burrell Ward

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Sean A YarrellDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN.
Sophia H BlythDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN.
Baxter P RogersDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN.
Anna HuangDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN.
Alexandra B Moussa-TooksDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, IN.ORCID 0000-0002-6778-8379
Neil D WoodwardDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN.
Stephan HeckersDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN.
Roscoe O BradyDepartment of Psychiatry, Beth Israel Deaconess Medical Center, McLean Hospital, and Harvard Medical School, Boston, MA.
Heather Burrell WardDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN.

Funding

Imaging Hippocampal Function in PsychosisR01MH070560 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HECKERS, STEPHAN · 2005 to 2025
$7.2M
Network Mediation of Experiential and Expressive Deficits in Psychotic DisordersR01MH116170 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Roscoe O. Brady, KATHRYN Eve LEWANDOWSKI · 2019 to 2026
$5.4M
Thalamocortical Networks in PsychosisR01MH102266 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WOODWARD, NEIL D. · 2014 to 2018
$2.3M
Longitudinal Assessment of Distinct Motor Learning Processes to Inform Mechanistic Models of Sensorimotor Function in PsychosisK23MH135215 · NIMH · TRUSTEES OF INDIANA UNIVERSITY · PI MOUSSA-TOOKS, ALEXANDRA · 2024 to 2025
$1.0M
Network-Targeted Neuromodulation for Nicotine Dependence in SchizophreniaK23DA059690 · NIDA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Heather Burrell Ward · 2024 to 2026
$557k
NIDA NIH HHS K23 DA059690NIMH NIH HHS K23 MH135215NIMH NIH HHS R01 MH070560NIMH NIH HHS R01 MH102266NIMH NIH HHS R01 MH116170
6 · The paper itself

Abstract

Background: Negative symptom severity predicts functional outcome and quality life in people with psychosis. However, negative symptoms are poorly responsive to antipsychotic medication and existing literature has not converged on their neurobiological basis. Previous work in small schizophrenia samples has observed that lower cerebellar-prefrontal connectivity is associated with higher negative symptom severity and demonstrated in a separate neuromodulation experiment that increasing cerebellar-prefrontal connectivity reduced negative symptom severity. We sought to expand this finding to test associations between cerebellar-prefrontal connectivity with negative symptom severity and cognitive performance in a large, transdiagnostic sample of individuals with psychotic disorders. Methods: In this study, 260 individuals with psychotic disorders underwent resting-state MRI and clinical characterization. Negative symptom severity was measured using the Positive and Negative Symptoms Scale, and cognitive performance was assessed with the Screen for Cognitive Impairment in Psychiatry. Using a previously identified cerebellar region as a seed, we performed seed to whole brain analyses and regressed connectivity against negative symptom severity, using age and sex as covariates. Results: Consistent with prior work, we identified relationships between higher cerebellar-prefrontal connectivity and lower negative symptom severity (r=-0.17, p=.007). Higher cerebellar-prefrontal connectivity was also associated with better delayed verbal learning (r=.13, p=.034). Conclusions: Our results provide further evidence supporting the relationship between cerebellar-prefrontal connectivity and negative symptom severity and cognitive performance. Larger, randomized, sham-controlled neuromodulation studies should test if increasing cerebellar-prefrontal connectivity leads to reductions in negative symptoms in psychosis.

Identifiers

PMID39574720
PMCPMC11580979

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.